The price, and that is confidential & was negotiated for a maximum of 300 huge number of doses, is somewhat less than the $19.50 per picture the United States agreed to buy a first shipment of hundred million doses of the identical vaccine, in series with what Reuters reported in November.
The EU document dated Nov. 18 was circulated internally right after the EU announced the supply package of its with Pfizer and its German partner BioNTech on Nov. eleven.
The EU drug regulator is likely to decide on Monday on endorsement for the Pfizer vaccine after the photo was authorised in several countries, like Britain as well as the United States.
On Thursday Belgian say secretary on your budget Eva De Bleeker released on Twitter a dining room table with costs Belgium will spend pharmaceutical companies for the COVID-19 vaccines of theirs. She retracted the piece of writing shortly after posting.
In this dinner table the Pfizer vaccine was suggested as costing Belgium 12 euros ($14.6) per dose, leading many to think that has been the entire cost agreed by way of the EU.
Other vaccines in the table were also shown with rates lower than prices disclosed by EU sources.
“There is , naturally, a complete fee along with a price upon delivery,” an EU official required in talks with vaccine creators told Reuters when directed to clarify the big difference between the EU and Belgian rates.
A spokesman for De Bleeker declined to comment on Monday, citing confidentiality requirements, but pointed to what De Bleeker told the Belgian parliament previous week. In that public hearing, De Beeker said Belgium’s budgeted price tags were still partial.
Under EU advance purchase deals for COVID 19 vaccines, the bloc agrees upfront payments with business enterprises to secure doses before they’re approved. Following approvals, EU governments are able to pay the rest to purchase reserved doses.
The EU has not revealed the upfront payment agreed with Pfizer.
But, it mentioned in October that it paid about one billion euros in downpayments to AstraZeneca, Sanofi and Johnson and Johnson for the shots of theirs, with an additional 1.45 billion euros budgeted for initial payments to Pfizer-BioNTech, Curevac and Moderna.
It’s since agreed supply deals with all 6 businesses and it is negotiating a seventh arrangement with Novavax.